Abstract
Background Malaria elimination is the goal for Bioko Island, Equatorial Guinea. Intensive interventions implemented since 2004 have reduced prevalence, but progress has stalled in recent years. A challenge for elimination has been malaria infections in residents acquired during travel to mainland Equatorial Guinea. We quantify how off-island contributes to remaining malaria prevalence on Bioko Island, and investigate the potential role of a pre-erythrocytic vaccine in making further progress towards elimination.
Methods We simulated malaria transmission on Bioko Island using a model calibrated based on data from the Malaria Indicator Surveys (MIS) from 2015-2018, including detailed travel histories and malaria positivity by rapid-diagnostic tests (RDTs), as well as geospatial estimates of malaria prevalence. Mosquito population density was adjusted to fit local transmission, conditional on importation rates under current levels of control and within-island mobility. We evaluated the impact of two pre-erythrocytic vaccine distribution strategies: mass treat and vaccinate, and prophylactic vaccination for off-island travelers. We propagated uncertainty through the model through an ensemble of simulations fit to the Bayesian joint posterior probability distribution of the geospatial prevalence estimates.
Results The simulations suggest that in Malabo, an urban city containing 80% of the population, there are some pockets of residual transmission, but a large proportion of prevalence is attributable to malaria importation by travelers. Outside of Malabo, prevalence was mainly attributable to local transmission. We assess the uncertainty in the local transmission vs. importation to be lowest within Malabo and highest outside. Using a pre-erythrocytic vaccine to protect travelers would have larger benefits than using the vaccine to protect residents of Bioko Island from local transmission. In simulations, mass treatment and vaccination had short-lived benefits, as malaria prevalence returned to current levels as the vaccine’s efficacy waned. Prophylactic vaccination of travelers resulted in longer-lasting reductions in prevalence. These projections were robust to underlying uncertainty in prevalence estimates.
Conclusions The modeled outcomes suggest that the volume of malaria cases imported from the mainland is a partial driver of continued endemic malaria on Bioko Island, and that continued elimination efforts on must account for human travel activity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We acknowledge support from the Bill \& Melinda Gates Foundation, Grant OPP1110495.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
None required
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All supporting data referred to in the manuscript may be found in a linked Figshare repository
